In a 7-2 vote, the U.S. Supreme Court ruled that an inter partes review (IPR) at the U.S. Patent and Trademark Office does not violate a defendant’s constitutional right to have a case determined by a federal court and jury. Congress created the process in 2011 to handle the large number of flimsy patent applications. The Houston-based Oil States International brought the case; pharmaceutical companies also called the IPR process “a threat to innovation.” Justices John Roberts and Neil Gorsuch were the dissenting votes. Continue reading Supreme Court Ruling Confirms Internal U.S. Patent Reviews